Richard KLAR

Person

Munich, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Oligonucleotide inhibiting the expression of Chop
- Patent number 11,781,136
- Issue date Oct 10, 2023
- Secarna Pharmaceuticals GmbH & Co. KG
- Richard Klar
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense oligonucleotides for inhibition of PD-L1 expression and t...
- Patent number 11,666,595
- Issue date Jun 6, 2023
- Secarna Pharmaceuticals GmbH & Co. KG
- Tamara Thelemann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
Oligonucleotides reducing the amount of CD73 mRNA and CD73 protein...
- Publication number 20240076673
- Publication date Mar 7, 2024
- Secarna Pharmaceuticals GmbH & Co KG
- Frank JASCHINSKI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Oligonucleotide for reducing the expression of angiotensin-converti...
- Publication number 20240067973
- Publication date Feb 29, 2024
- The First Affiliated Hospital of Sun Yat-sen University
- Frank JASCHINSKI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PD-1-specific antisense oligonucleotide and its use in therapy
- Publication number 20230183708
- Publication date Jun 15, 2023
- Secarna Pharmaceuticals GmbH & Co KG
- Richard KLAR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibitor of metadherin expression
- Publication number 20230067620
- Publication date Mar 2, 2023
- Secarna Pharmaceuticals GmbH & Co KG
- Frank JASCHINSKI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Modified antisense oligonucleotide for inhibition of FoxP3 expression
- Publication number 20220372482
- Publication date Nov 24, 2022
- Secarna Pharmaceuticals GmbH & Co KG
- Frank JASCHINSKI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Oligonucleotide based ex vivo cell therapy
- Publication number 20220372479
- Publication date Nov 24, 2022
- Secarna Pharmaceuticals GmbH & Co KG
- Frank JASCHINSKI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PD-L1 antisense oligonucleotides for use in tumor treatment
- Publication number 20220220485
- Publication date Jul 14, 2022
- Secarna Pharmaceuticals GmbH & Co KG
- Frank JASCHINSKI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGONUCLEOTIDE INHIBITING THE EXPRESSION OF CHOP
- Publication number 20200283764
- Publication date Sep 10, 2020
- Secarna Pharmaceuticals GmbH & Co KG
- Richard KLAR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Immunosuppression-Reverting Oligonucleotides Inhibiting the Express...
- Publication number 20200163988
- Publication date May 28, 2020
- Secarna Pharmaceuticals GmbH & Co KG
- Richard KLAR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Novel Approach for Treating Cancer
- Publication number 20200009181
- Publication date Jan 9, 2020
- Secarna Pharmaceuticals GmbH & Co KG
- Tamara HILMENYUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Richard KLAR

Person

Patents Grantslast 30 patents

Oligonucleotide inhibiting the expression of Chop

Antisense oligonucleotides for inhibition of PD-L1 expression and t...

Patents Applicationslast 30 patents

Oligonucleotides reducing the amount of CD73 mRNA and CD73 protein...

Oligonucleotide for reducing the expression of angiotensin-converti...

PD-1-specific antisense oligonucleotide and its use in therapy

Inhibitor of metadherin expression

Modified antisense oligonucleotide for inhibition of FoxP3 expression

Oligonucleotide based ex vivo cell therapy

PD-L1 antisense oligonucleotides for use in tumor treatment

OLIGONUCLEOTIDE INHIBITING THE EXPRESSION OF CHOP

Immunosuppression-Reverting Oligonucleotides Inhibiting the Express...

Novel Approach for Treating Cancer